Table 2.
Sex differences within the COVID-19 group, not adjusted for age. Analysed with chi-2 test
| Characteristics | Women | Men | χ2 | P-value |
|---|---|---|---|---|
| Breathlessness occurrencea | 403/555 (73%) | 550/769 (72%) | 0.2 | .66 |
| Breathlessness reliefb | 130/403 (32%) | 156/550 (28%) | 1.7 | .20 |
| Anxiety occurrencea | 371/510 (73%) | 454/679 (67%) | 4.7 | .029 |
| Anxiety reliefb | 225/371 (61%) | 268/454 (59%) | 0.2 | .64 |
| Delirium occurrencea | 176/455 (39%) | 257/635 (41%) | 0.4 | .55 |
| Delirium reliefb | 27/176 (15%) | 45/257 (18%) | 0.4 | .55 |
| Respiratory secretions occurrencea | 232/570 (41%) | 399/787 (51%) | 13.3 | <.001 |
| Respiratory secretions reliefb | 82/232 (35%) | 141/399 (35%) | 0.00 | .999 |
| Nausea occurrencea | 55/430 (13%) | 45/592 (8%) | 7.6 | .006 |
| Nausea reliefb | 21/55 (38%) | 19/45 (42%) | 0.2 | .68 |
| Pain occurrencea | 345/548 (63%) | 441/735 (60%) | 1.2 | .28 |
| Pain reliefb | 236/345 (68%) | 302/441 (69%) | 0.001 | .98 |
| Close friend(s) and/or relative(s) present with or without staff at the time of deatha | 149/598 (25%) | 217/821 (26%) | 0.4 | .52 |
| Someone present at the time of deatha | 330/598 (55%) | 475/821 (58%) | 1.0 | .32 |
| Parenteral fluids/nutrition or enteral-tube feeding given during the last 24 hours | 211/606 (35%) | 324/827 (39%) | 2.8 | .092 |
a“Don’t know” was an optional answer for the questions on symptom occurrence, and these responses were excluded from the analysis. Therefore, numbers do not sum to group totals
bAlternatives for answers on symptom relief were “Completely”, “Partially” and “Not at all”